Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
DNA - Ginkgo Bioworks Holdings, Inc.
Market Cap 4.25B P/E - EPS this Y 37.00% Ern Qtrly Grth -
Income -853.81M Forward P/E -8.87 EPS next Y 37.90% 50D Avg Chg 6.00%
Sales 208.7M PEG -0.09 EPS past 5Y - 200D Avg Chg 15.00%
Dividend N/A Price/Book 2.63 EPS next 5Y 31.20% 52W High Chg -58.00%
Recommedations 3.70 Quick Ratio 5.12 Shares Outstanding 1.71B 52W Low Chg 82.00%
Insider Own 6.41% ROA -21.76% Shares Float 1.33B Beta 1.42
Inst Own 82.72% ROE -65.81% Shares Shorted/Prior 289.73M/270.83M Price 2.04
Gross Margin 80.44% Profit Margin - Avg. Volume 23,741,956 Target Price 1.43
Oper. Margin -469.12% Earnings Date Mar 1 Volume 30,833,852 Change -12.82%
Healthcare | Biotechnology | United States
About Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Ginkgo Bioworks Holdings, Inc. News
05/15/24 Ginkgo Bioworks to Participate in Two Conferences in May
05/14/24 Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japan
05/13/24 Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSE
05/11/24 Ginkgo Bioworks Holdings First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
05/09/24 Ginkgo Bioworks Reports First Quarter 2024 Financial Results
05/07/24 GreenLab Partners with Ginkgo Bioworks to Scale Up Production of Brazzein, a Novel Sweetener
05/06/24 Ginkgo Bioworks Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
05/05/24 Recent uptick might appease Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) institutional owners after losing 25% over the past year
05/02/24 Ginkgo Bioworks Announces Date of First Quarter 2024 Results Presentation
04/29/24 Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors
04/16/24 Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products
04/11/24 Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces "Lab Data as a Service"
04/11/24 Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets
04/10/24 Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain
04/10/24 Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles Outbreaks
04/08/24 IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service
04/04/24 Ginkgo Bioworks to Host 5th Annual Ferment Conference
04/03/24 Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing
04/02/24 Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy Assets to Strengthen Next-Gen CAR Designs
03/28/24 Ginkgo Bioworks Awarded DARPA Funding to Produce Novel Proteins to Control Ice in Extreme Cold Weather Environments
DNA Chatroom

User Image mbleazie Posted - 5 hours ago

$DNA Avoiding reverse split If substantial layoffs occur before July as rumored reflect a serious commitment to OPEX reduction / focus on the customer service through automation pivot and Powell cuts or maintains rates then a reverse split might be avoidable. I hope that Jason can gut it out and do what needs to be done.

User Image mbleazie Posted - 16 hours ago

$DNA https://www.fool.com/investing/2024/05/18/is-ginkgo-bioworks-holdings-stock-a-buy/

User Image prman Posted - 16 hours ago

$DNA everyone wants to see Jason buy stock now.... personally, I'd be more impressed if they show some revenue and stock goes up significantly and THEN he buys to show confidence

User Image rxptgh Posted - 16 hours ago

$DNA insider buying wow 😮

User Image jaydilks Posted - 17 hours ago

$DNA https://x.com/thewinningdiff1/status/1791975315197067651?s=61&t=kw_xII2XZ5e1QHzmVVzmLQ

User Image traderXO Posted - 18 hours ago

$DNA insiders buying is a good sign

User Image LMSS Posted - 19 hours ago

$DNA Insiders are buying Institutions own 83% Institutions know what they do Biologics is the future! When? Who knows? Long term bet Great partnerships

User Image Termitrader Posted - 20 hours ago

$DNA let's get a green week this week.

User Image mbleazie Posted - 1 day ago

$DNA if it were not for the shorts, it would run well. Patience is what is needed. Cautiously bullish

User Image mikey_bear Posted - 1 day ago

$DNA I wonder if Ginkgo will make a pitch to get Ilya Sutskever. JK seemed pretty excited when he thought Altman was available

User Image JasonLg Posted - 1 day ago

$DNA This claim of 108 Million shares traded after hours is PURE NONSENSE! The true numbers are 31 million traded during daytime - per Yahoo Finance 111 thousand (not MILLION) traded after hours - per Nasdaq Be careful who you listen to

User Image Shaffin786 Posted - 1 day ago

$DNA 🧬🧬🚀🚀 Subject: Enthusiasm for Ginkgo Bioworks - Encouraging Leadership Investment Dear Investor Relations Team, We were excited to learn about Shyam Shankar's continued faith in Ginkgo Bioworks through his recent investment. This vote of confidence is a positive signal for the company's future. Building on this momentum, it would be a powerful gesture for Jason Kelly, as co-founder and CEO, to consider a personal investment in Ginkgo Bioworks, particularly at this attractive share price. Such a move would demonstrate strong leadership commitment and potentially deter short sellers. Thank you for your time and consideration.

User Image Shaffin786 Posted - 1 day ago

$DNA 🧬🧬🚀🚀 Attention Short Sellers: Ginkgo Bioworks ($DNA) Might Be a Ticking Time Bomb Many investors are overlooking the potential for a major short squeeze in Ginkgo Bioworks. The key lies in shares available. This creates a dangerous situation for short sellers. Here's why: Short interest in $DNA has been rising. Combine that with a restricted shorting environment on the NYSE following Friday's price drop, and you have a recipe for a potential squeeze. Online communities are already buzzing about this. My prediction: The absolute lowest point for Ginkgo Bioworks was reached on Friday, May 10th, 2024, at 1:25 PM Eastern Time.

User Image zassy Posted - 1 day ago

$DNA well said. And if Jason buys this rips 50%. I wouldn’t put it out of the question. He has millions he’s pocketed, and a $1m gesture would go far to help investor relations

User Image McLovin13 Posted - 1 day ago

$DNA dude at this point we get it. You hate Dilks. Honestly, I like him. He posts (mostly) interesting content and he has conviction for the most part. Has he been wrong? Absolutely. But so has ARK and Baillie Gifford. Go read Baillie’s thesis on Ginkgo. Personally, I see the vision, like 100000%. I struggle with, can they execute and make the right moves NOW so we get to what we all believe Ginkgo COULD be. When I see the Palantir cto buy, it does give me confidence to take a shot. He’s a genius if you ever listen to him. He sees something that most of us now question. Ideally, I’d love to see that pos CEO make a substantial buy down here. We know he sold millions worth at higher levels. If the Carvana CEO can do it, then so can Jason Kelly. Unless maybe Jason Kelly doesn’t believe in his own company at this point… My question is; at this point, are you only here to harass Dilks? If so, prob better ways to spend your time amigo. Cheers.

User Image Hugh_G_Rexion Posted - 1 day ago

$DNA Dilks is a really special type of moron

User Image Hugh_G_Rexion Posted - 1 day ago

$DNA Data last updated May 17, 2024 08:00 PM ET. This page will resume updating on May 20, 2024 04:00 PM ET. Consolidated Last Trade $0.8149 -0.0241 (-2.87%) After-Hours Volume 111,087 After-Hours High $0.815 (06:35:00 PM) After-Hours Low $0.8005 (05:12:28 PM)

User Image Hugh_G_Rexion Posted - 1 day ago

$DNA DILKSDO

User Image bobaboiz Posted - 1 day ago

$DNA in at .8004 ✌️😎😬☠️

User Image RayCatcher Posted - 1 day ago

$DNA I’m here for the Hugh x Dilks match

User Image JasonLg Posted - 1 day ago

$DNA I'm not at all sure how accurrate this is. This volume doesn't show up on TOS https://www.nasdaq.com/market-activity/stocks/dna/after-hours Says after hours volume is 90 thousand shares traded

User Image honestinvt7672 Posted - 1 day ago

$DNA fucking scam this co is

User Image papertrader_US Posted - 1 day ago

$DNA the first one was filed for another 18M shares a few days ago. Then this 18M today. If another one comes out for 18M next week .. those 3 are going at it again? That’ll be funny that they announced a poor salary and no-where-in-sight comp plan then shower the market with 18M each when share price is ATL. Or am I missing the fine print?

User Image Hugh_G_Rexion Posted - 1 day ago

$DNA what a moron dilks is 65,000 shares have traded after hours toolio

User Image Suspect123 Posted - 1 day ago

$DNA dilks is our last hope. Got Dilk????

User Image jaydilks Posted - 1 day ago

$DNA 108 Million shares traded after hours !!!!! Pressure valve RELEASED.

User Image McLovin13 Posted - 1 day ago

$DNA a Jason Kelly insider buy would do the trick. Just saying - come on Jason. Put on your big boy pants and buy back 1 or 2 million shares dirt cheap. You sold millions muchhh higher, so we know you’ve got the money 🤷🏻‍♂️

User Image Hugh_G_Rexion Posted - 1 day ago

$DNA Dear Board, I lost 30K on this stock Bought 100,000 at $1.92 Sold 100,000 at $1.62 so do what you want with what I say But whatever you do - stay away from this clown dilks. He sold his $10 basis stock at $1.04 and now he is back on this board giving advice. It's really sad. The only reason I don't block him is I want to hear his spin on why the stock was delisted.

User Image jaydilks Posted - 1 day ago

$DNA There’s only ONE etf that has DNA in the top 15 holdings and that is $ARKG. I say this because there are 17 other ETFs that have had it in the top 15 when it was above $1. Many are not remitted to own it under $1. Today is Options Expiration. We might get a 20% move UP, next week. I believe the thought of a Reverse Split will be put in the rearview mirror as we enter June. Next week the remaining CHIPs funding is dispersed in smaller allotments and wouldn’t be surprised if DNA got a $250-$500 Mill Grant. Not a guarantee.

User Image Hugh_G_Rexion Posted - 1 day ago

$DNA looking strong into the close

Analyst Ratings
BTIG Sell May 15, 24
Morgan Stanley Equal-Weight May 15, 24
William Blair Underperform May 10, 24
TD Cowen Outperform Mar 1, 24
Goldman Sachs Sell Jan 23, 24
Goldman Sachs Sell Jan 22, 24
Raymond James Market Perform Nov 15, 23
Raymond James Market Perform Nov 14, 23
BTIG Neutral Nov 9, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Dmytruk Mark E. See remarks See remarks Feb 01 Sell 1.21 39,569 47,878 761,737 02/06/24
Kelly Jason R See remarks See remarks Jan 03 Sell 1.55 200,000 310,000 3,894,680 01/05/24
Dmytruk Mark E. See remarks See remarks Jan 02 Sell 1.54 45,794 70,523 716,098 01/05/24
Canton Barry 10% Owner 10% Owner Dec 20 Sell 1.77 75,300 133,281 12,374,544 12/22/23
Kelly Jason R See remarks See remarks Dec 20 Sell 1.77 200,000 354,000 4,094,680 12/22/23
Shetty Reshma P. See remarks See remarks Dec 20 Sell 1.77 75,300 133,281 12,374,544 12/22/23
Canton Barry 10% Owner 10% Owner Dec 13 Sell 1.48 75,300 111,444 12,412,194 12/15/23
Kelly Jason R See remarks See remarks Dec 13 Sell 1.48 200,000 296,000 4,294,680 12/15/23
Shetty Reshma P. See remarks See remarks Dec 13 Sell 1.48 75,300 111,444 12,412,194 12/15/23
Canton Barry 10% Owner 10% Owner Dec 06 Sell 1.32 75,300 99,396 12,449,844 12/08/23
Kelly Jason R See remarks See remarks Dec 06 Sell 1.32 200,000 264,000 4,494,680 12/08/23
Shetty Reshma P. See remarks See remarks Dec 06 Sell 1.32 75,300 99,396 12,449,844 12/08/23
Dmytruk Mark E. See remarks See remarks Dec 01 Sell 1.39 42,402 58,939 676,844 12/06/23
Shetty Reshma P. See remarks See remarks Nov 29 Sell 1.4 75,300 105,420 12,487,494 12/01/23
Kelly Jason R See remarks See remarks Nov 29 Sell 1.4 200,000 280,000 4,694,680 12/01/23
Canton Barry 10% Owner 10% Owner Nov 29 Sell 1.4 75,300 105,420 12,487,494 12/01/23
Canton Barry 10% Owner 10% Owner Nov 22 Sell 1.41 75,300 106,173 12,525,144 11/27/23
Kelly Jason R See remarks See remarks Nov 22 Sell 1.41 200,000 282,000 4,894,680 11/27/23
Shetty Reshma P. See remarks See remarks Nov 22 Sell 1.41 75,300 106,173 12,525,144 11/27/23
Shetty Reshma P. See remarks See remarks Nov 08 Sell 1.4 75,300 105,420 12,600,444 11/13/23
Kelly Jason R See remarks See remarks Nov 08 Sell 1.4 200,000 280,000 5,294,680 11/13/23
Canton Barry 10% Owner 10% Owner Nov 08 Sell 1.4 75,300 105,420 12,600,444 11/13/23
HENRY CHRISTIAN O Director Director Nov 02 Sell 1.39 4,500 6,255 1,234,378 11/06/23
Dmytruk Mark E. See remarks See remarks Nov 01 Sell 1.5 37,229 55,844 634,206 11/06/23
Shetty Reshma P. See remarks See remarks Nov 01 Sell 1.43 75,300 107,679 12,638,094 11/03/23
Canton Barry 10% Owner 10% Owner Nov 01 Sell 1.43 75,300 107,679 12,638,094 11/03/23
Kelly Jason R See remarks See remarks Nov 01 Sell 1.43 200,000 286,000 5,494,680 11/03/23
Shetty Reshma P. See remarks See remarks Oct 25 Sell 1.47 75,300 110,691 12,675,744 10/27/23
Kelly Jason R See remarks See remarks Oct 25 Sell 1.47 200,000 294,000 5,694,680 10/27/23
Canton Barry 10% Owner 10% Owner Oct 25 Sell 1.47 75,300 110,691 12,675,744 10/27/23
Canton Barry 10% Owner 10% Owner Oct 18 Sell 1.65 75,300 124,245 12,713,394 10/20/23
Kelly Jason R See remarks See remarks Oct 18 Sell 1.65 200,000 330,000 5,894,680 10/20/23
Shetty Reshma P. See remarks See remarks Oct 18 Sell 1.65 75,300 124,245 12,713,394 10/20/23
Kelly Jason R See remarks See remarks Oct 11 Sell 1.71 200,000 342,000 6,094,680 10/13/23
Shetty Reshma P. See remarks See remarks Oct 04 Sell 1.64 75,300 123,492 12,788,694 10/06/23
Kelly Jason R See remarks See remarks Oct 04 Sell 1.64 200,000 328,000 6,294,680 10/06/23
Canton Barry 10% Owner 10% Owner Oct 04 Sell 1.64 75,300 123,492 12,788,694 10/06/23
HENRY CHRISTIAN O Director Director Oct 02 Sell 1.78 4,499 8,008 1,238,878 10/06/23
Dmytruk Mark E. See remarks See remarks Oct 01 Sell 1.76 42,237 74,337 586,393 10/04/23
Kelly Jason R See remarks See remarks Sep 27 Sell 1.79 200,000 358,000 6,494,680 09/29/23
Shetty Reshma P. See remarks See remarks Sep 27 Sell 1.79 75,300 134,787 12,826,344 09/29/23
Canton Barry 10% Owner 10% Owner Sep 27 Sell 1.79 75,300 134,787 12,826,344 09/29/23
Shetty Reshma P. See remarks See remarks Sep 20 Sell 1.8 75,300 135,540 12,863,994 09/22/23
Kelly Jason R See remarks See remarks Sep 20 Sell 1.8 200,000 360,000 6,694,680 09/22/23
Canton Barry 10% Owner 10% Owner Sep 20 Sell 1.8 75,300 135,540 12,863,994 09/22/23
Shetty Reshma P. See remarks See remarks Sep 06 Sell 2.18 75,300 164,154 12,939,294 09/08/23
Canton Barry 10% Owner 10% Owner Sep 06 Sell 2.18 75,300 164,154 12,939,294 09/08/23
HENRY CHRISTIAN O Director Director Sep 05 Sell 2.23 4,499 10,033 1,243,377 09/06/23
Dmytruk Mark E. See remarks See remarks Sep 01 Sell 2.24 41,417 92,774 543,585 09/06/23
Canton Barry 10% Owner 10% Owner Aug 30 Sell 2.26 75,300 170,178 12,976,944 09/01/23